Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)

BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) comprises 31% of lymphomas in the United States. Although it is an aggressive type of lymphoma, 40% to 50% of patients are cured with treatment. The study objectives were to identify patient factors associated with treatment and survival in DLBCL. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Griffiths, Robert, Gleeson, Michelle, Knopf, Kevin, Danese, Mark
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995801/
https://www.ncbi.nlm.nih.gov/pubmed/21073707
http://dx.doi.org/10.1186/1471-2407-10-625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995801/
https://www.ncbi.nlm.nih.gov/pubmed/21073707
http://dx.doi.org/10.1186/1471-2407-10-625

Ejemplares similares